Inhibikase Therapeutics Inc (IKT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inhibikase Therapeutics Inc   (NASDAQ: IKT)


Inhibikase Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Inhibikase Therapeutics Inc's ROI in the second quarter of 2026?
Inhibikase Therapeutics Inc recorded a cumulative net loss of $-61 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -42.39%.

Within the Healthcare sector 440 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3637, from total ROI ranking in the first quarter of 2026 at 4313.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 114.88 % 166.3 % 298.19 % 1421.03 % 597.78 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 153 168 176 75 83
Return On Investment (TTM) -42.39 % -40.62 % -45.61 % -55.71 % -62.34 %
IKT's Overall Ranking # 3637 # 4313 # 3895 # 3997 # 4134
Seq. Investment Change TTM 14.02 % 18.58 % 23.7 % 28.48 % 41.31 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -61 -51 -48 -48 -42

IKT Company Profile >> Back to IKT Roi Comparisons >> See Annual IKT Return On Investment



Return On Investment IKT's Ranking
Within: No.
Industry # 62
Sector # 441
Overall # 3637

Return On Investment Statistics
High Average Low
-40.62 %
-92.82 %
-347.91 %
(Mar 31 2026)   (Sep 30 2024)







Financial Statements
Inhibikase Therapeutics Inc's II. Quarter Investments $ 153 Millions IKT's Balance sheet
Inhibikase Therapeutics Inc's II. Quarter Income $ -20 Millions Quarterly IKT's Income Statement
IKT's Income by Division See IKT's Income by Division


IKT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 173 95 11 21 38
Y / Y Investment Growth 82.26 % 757.12 % -47.89 % -44.71 % -
Net Income in Millions -48 -28 -19 -18 -15
Y / Y Net Income Growth - - - - -
Annual Return On Investment -27.91 % -29.01 % -171.93 % -85 % -38.49 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IKT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IKT's Competitors
Subscribers only: Roi for Inhibikase Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for IKT's Customers

Other Ratios
IKT's Roa IKT's Inventory Turnover Ratio IKT's Growth Rates IKT's Dividend Statistics
IKT's Profitability Ratios IKT's Asset Turnover Ratio IKT's Dividend Growth
IKT's Roe IKT's Valuation Ratios IKT's Financial Strength Ratios IKT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-04T17:23:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.